Previous studies have also highlighted the GOPC-ROS1 fusion as a resistance marker to chemotherapy in lung cancer, indicating that this fusion may be prognostic for a poor chemotherapeutic outcome.[41] As this patient achieved a gross total resection, there was no indication for adjuvant chemotherapy or radiation therapy. This evidence concerns the gene ROS1 and lung cancer.